Pharmaceuticals

Cohort study compares weight loss effects of tirzepatide and semaglutide

bexib
By bexib 0 Min Read

The JAMA study aimed to determine how weight loss differs between patients receiving tirzepatide and those receiving semaglutide in a clinical population of overweight adults.

You Might Also Like

Using the body as a “bioreactor” – A regenerative medicine expert talks about the future of this field

New immunotherapy developed at UCL shows promising results in treating bone cancer

Pharma Pulse 6/21/24: Improving Access to Clinical Trials through Decentralization and Flexible Design, Insulin Pen Shortage in South Africa, and More

Can BioNTech maintain its mRNA pipeline post-COVID? Oncology is next.

APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology

Share This Article
Previous Article Credit Card Float: What It Is & How To Avoid It (2024)
Next Article Super fast, super smart: Haas and Phillips machine tools bring about a new era in Indian manufacturing
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Progress of metal cutting technology: Innovative innovation, sustainability, and future labor
Manufacturing
Ceratizit showcases innovation, sustainability and cutting-edge solutions at IMTEX 2025
Manufacturing
Goldman launches an internal GEN AI Assistant with 10K employees
Banking
Taiwan emerges as key player in Indian machine tools market with 20.8% growth
Manufacturing